GYNECOLOGY

7: CD101 Gel formulation is highly efficacious against azole-resistant Candida albicansin a rat model of vulvovaginal candidiasis

May 2, 2017 by in GYNECOLOGY Comments Off on 7: CD101 Gel formulation is highly efficacious against azole-resistant Candida albicansin a rat model of vulvovaginal candidiasis

Objectives The efficacy of intravaginally (IVG) administered CD101, a novel, long-acting and highly stable echinocandin formulated as a gel, was compared to marketed miconazole (MCZ) and nystatin (NYS) creams and…

read more

3: Detection of macrolide resistance-mediating mutations among women with mycoplasma genitalium infection in the preventing vaginal infections trial

May 2, 2017 by in GYNECOLOGY Comments Off on 3: Detection of macrolide resistance-mediating mutations among women with mycoplasma genitalium infection in the preventing vaginal infections trial

Objectives Mycoplasma genitalium (MG) is frequently detected in women and associated with a number of adverse reproductive health outcomes. Macrolide resistance-mediating mutations (MRMM) in region V of the 23S rRNA…

read more

4: Hormonal contraception is associated with stability and lactobacillus-dominance of the vaginal microbiota in a two-year observational study

May 2, 2017 by in GYNECOLOGY Comments Off on 4: Hormonal contraception is associated with stability and lactobacillus-dominance of the vaginal microbiota in a two-year observational study

Objectives Hormonal contraception (HC) has been associated with a reduced risk of bacterial vaginosis (BV). We conducted a prospective study to evaluate the relationship between the composition and structure of…

read more

1: Associations between serum estrogen, vaginal microbiota and vaginal glycogen in postmenopausal women

May 2, 2017 by in GYNECOLOGY Comments Off on 1: Associations between serum estrogen, vaginal microbiota and vaginal glycogen in postmenopausal women

Objectives To identify associations between serum estrogen, vaginal glycogen and the composition of the vaginal microbial community. Methods Post-menopausal women age 40-62 enrolled in a hot flash treatment trial answered questions…

read more
Get Clinical Tree app for offline access